IFNGR1 and neoplasm: Secondly, while it has been demonstrated that loss of IFNγR/JAK/STAT signaling can promote CAR-T resistance25, our data suggests that the effect of disrupting this pathway is not necessarily uniform and is instead wholly dependent upon context with respect to the tumor and tissue microenvironment.